A

Annovis Bio
D

ANVS

6.62000
USD
-0.16
(-2.36%)
Market Closed
Volume
4,790
EPS
-2
Div Yield
-
P/E
-2
Market Cap
91,337,742
OverviewSignalsIdeasNews
Related Instruments
    A
    APLS
    -1.750
    (-6.24%)
    26.280 USD
    B
    BGNE
    -4.220
    (-2.18%)
    189.320 USD
    B
    BLPH
    0
    (0%)
    0.000000 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    C
    CTMX
    -0.08670
    (-8.67%)
    0.91330 USD
    D
    DARE
    -0.37000
    (-10.42%)
    3.18000 USD
    F
    FATE
    -0.04500
    (-2.17%)
    2.02500 USD
    M
    MEIP
    -0.10000
    (-3.33%)
    2.90000 USD
    More
News

Title: Annovis Bio

Sector: Healthcare
Industry: Biotechnology
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the companyconsists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.